Content area
Full Text
ABSTRACT:
In-vitro controlled release of glipizide was studied from modified pulsincaps prepared by using different proportions of the polymer HPMC. Glipizide - HPMC mixtures were prepared in the ratios 5:1, 5:2, 5:3 and 5:4 respectively. These mixtures were evaluated for micromeritic properties and to confirm the reproducibility of method of mixing. Micromertic properties of the pure drug glipizide and glipizide - HPMC mixtures were improved by the incorporation of spray-dried lactose (pharmatose) at 15% of the weight of the drug. Drug polymer interaction studies were performed on the selected drug - polymer mixtures and on the pure drug , glipizide by using FTIR and DSC. These studies showed no drug polymer interactions.Drug - polymer mixture equivalent to 10mg of glipizide was used for the preparation of modified pulsincaps. The prepared modified pulsincaps were evaluated for weight variation, drug content and drug release from the prepared modified pulsincaps. Glipizide release from the prepared modified pulsincaps was slow and extended for a period of time not less than 10 hrs, depending upon the concentration of the polymer used. Drug release was diffusion controlled and followed zero order kinetics. The release of glipizide from GH1 and GH2 pulsincaps was close to the release of glipizide from a commercial SR tablet Glytop.
KEYWORDS: Glipizide, , Pulsincaps, HPMC, pharmatose, zero order , peppas model.
INTRODUCTION:
Diabetes is the fifth leading cause of deaths in the U.S. as well as the leading cause of adult blindness and responsible for 50% of heart attacks, 75% of strokes and 85% of gangrenous leg amputations1. Glipizide is widely prescribed oral hypoglycemic drug in the treatment of type 2 diabetes mellitus. It has short biological half-life (2-4 hrs) 2. The conventional dosage forms of glipizide suffer from adverse side effects, G.I. Disturbances that may lead to non-compliance to the patient. Hence, it is necessary to develop a formulation of controlled release of drug delivery system for the drug glipizide. There are only a few reports 3-5 on the formation of oral controlled drug release products of the drug glipizide.
In the present study, glipizide pulsincaps were prepared by modified pulsincap technique with the hydrophilic polymer HPMC 4 KM and were evaluated for uniformitys of weight, uniformity in drug content and in vitro drug release...